Zachary Green, CPhT, Director of Professional Affairs at the Pharmacy Technician Certification Board (PTCB) and Director of the Pharmacy Technician Educators Council (PTEC), shares his experience and insights on pharmacy technician certification, career opportunities and more.

Marketing your compounding pharmacy in the digital space is no longer an option — it’s a necessity. Skilled freelancers can help you get started or expand your digital footprint by providing compelling written content, engaging designs or strategic social media management. But how do you know you’re hiring the right professionals for the job? Ask these essential questions during the interview process.

As one of the most studied synthetic drugs in modern history, quinacrine HCI was first used as an antimalarial and later to treat rheumatic skin diseases, including lupus. With May designated as Lupus Awareness month, learn more about quinacrine HCI and the twists and turns of its storied past.

Menopause causes more than hot flashes, mood swing and changes in libido; it also impacts diseases caused by shifting changes in the vaginal microbiome. Bridget Briggs, MD, sheds light on the vaginal microbiome, its influences on a woman’s health throughout various life stages, as well as how HRT helps mediate changes — and associated diseases — in the vaginal microbiome during menopause.

In today's fast-paced world, maintaining optimal health can be a challenge. Despite the best intentions, many adults struggle to meet their nutritional needs through diet alone — that's where supplements can play a crucial role.

Dr. Loyd V. Allen, Jr., PhD, RPh, FACA, a trailblazer in the compounding industry who was highly regarded by students, colleagues and regulatory agencies, passed away on April 23, 2024.

In recognition of National Infertility Awareness Week, April 21-27, PCCA Director of Clinical Services Sara Hover, RPh, FAARM, discusses how fertility is increasingly viewed as an indicator of overall health; how the intertwine of metabolic balance, hormone production and mitochondria impact fertility; as well as a way compounders can help those whose individual needs exceed commercially available medicines.

Compounding pharmacists are committed to helping their patients live healthier, better lives —and key to this is ensuring their patients have continuing access to lawfully prescribed, personalized medications tailored to their individual needs.

Our Profiles in Personalized Medicine highlights Matthew McLachlan, BPharm, MPS, co-owner of O’Hara's Pharmacy 777 Kalamunda in Kalamunda, Western Australia. Matthew shares what motivated him to become a compounding pharmacist, how his pharmacy promotes compounding in their community and more. He and co-owner Andrew Mason, BPharm, MPS, have been proud PCCA members since 2018.

In February, the FDA approved the first and only oral treatment for eosinophilic esophagitis (EoE) that contains the active pharmaceutical ingredient (API) budesonide at a strength of 2 mg/10mL, which may sound familiar to many compounders.1 How does this affect compounders and what other potential options are available to patients?